Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/17/2025

Nystatin Treatment Duration and Efficacy

Standard Treatment Duration

  • The Infectious Diseases Society of America recommends nystatin suspension 4-6 mL (400,000-600,000 units) four times daily for 7-14 days, with treatment extended for at least 48 hours after symptoms disappear and cultures confirm eradication 1, 2
  • The CDC guidelines recommend nystatin 100,000-unit vaginal tablets once daily for 14 days for uncomplicated vulvovaginal candidiasis 3, 4

Extended Use Beyond 14 Days: Approved Scenarios

  • The IDSA guidelines for complicated vulvovaginal candidiasis recommend 14 days of treatment for C. glabrata infections specifically 5
  • The IDSA recommends continuing treatment for at least 48 hours after symptom resolution and negative cultures, which may extend beyond 14 days in some cases 1
  • For denture-related candidiasis, extended therapy beyond 14 days with concurrent denture disinfection may be required 1, 2

Important Caveats

  • For moderate-to-severe oral candidiasis, fluconazole (100-200 mg daily for 7-14 days) is superior to nystatin and should be first-line 5, 1
  • Nystatin has lower efficacy than azoles for most indications, with clinical cure rates of only 32-54% compared to 100% with fluconazole in some populations 1
  • If no clinical response occurs within 48-72 hours, consider alternative diagnosis or resistant organisms rather than simply extending nystatin duration 2
  • Topical nystatin is inadequate for esophageal candidiasis; systemic therapy is required 1